Annals of Medicine (Dec 2022)

A new prediction model for giant cell arteritis in patients with new onset headache and/or visual loss

  • Walid Moudrous,
  • Leo H. Visser,
  • Tansel Yilmaz,
  • Marjan H. Wieringa,
  • Tim Alleman,
  • Jörgen Rovers,
  • Mark P.W.A. Houben,
  • Paula M. Janssen,
  • Johan J. B. Janssen,
  • Pieter L. Rensma,
  • Geert J. F. Brekelmans

DOI
https://doi.org/10.1080/07853890.2022.2130971
Journal volume & issue
Vol. 54, no. 1
pp. 2770 – 2776

Abstract

Read online

Objective The gold standard for diagnosis of giant cell arteritis (GCA) is a temporal artery biopsy (TAB). We sought for a clinical useful model to predict when an invasive TAB is not necessary to confirm GCA.Methods A prospective cohort study was conducted with patients > 50 years with possible GCA, presenting with newly onset headache and/or visual loss. Demographical, clinical, laboratory findings and histological data were collected.Results Fifty-six (70%) of the 94 patients showed 1 or more halos of the superficial temporal artery branches. Ultrasound-guided biopsy was positive in 28 patients (30%). Four independent variables predicted a positive TAB: weight loss, bilateral headache, positive halo sign and thrombocytosis. The ROC of the model had an area under the curve of 0.932 with a PPV of 83% and a NPV of 94%.Conclusions Weight loss, bilateral headache, a positive halo sign with duplex and thrombocytosis are the most important clinical and laboratory predictors for GCA in a selected group of patients.Significance In patients > 50 years presenting with new onset headache or visual loss with 3 or more of the above mentioned risk factors, a biopsy of the temporal artery is not needed to confirm the diagnosis GCA.KEY MESSAGESIn our study biopsy of the temporal artery was positive in 30% of the patients with possible GCAWeight loss, bilateral headache, a positive halo sign on duplex and thrombocytosis are predictors for GCAThe halo sign had a high sensitivity but a low specificity for a biopsy proven GCA

Keywords